FORM 4
[ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Blobel Friedhelm 		2. Issuer Name and Ticker or Trading Symbol

SCICLONE PHARMACEUTICALS INC [ SCLN ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
President, CEO, Director
(Last)          (First)          (Middle)

950 TOWER LANE, SUITE 900 		3. Date of Earliest Transaction (MM/DD/YYYY)

10/13/2017
(Street)

FOSTER CITY, CA 94404
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   10/13/2017     M    95000   A   (1) 237299   (2) D    
Common Stock   10/13/2017     A    150000   (3) A $0.00   387299   D    
Common Stock   10/13/2017     D    387299   D $11.18   0   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy)   (4) $5.13   10/13/2017     D         142610      (5) 5/12/2021   Common Stock   142610   $6.05   (6) 0   D    
Non-Qualified Stock Option (right to buy)   (4) $6.22   10/13/2017     D         200000      (7) 3/15/2022   Common Stock   200000   $4.96   (6) 0   D    
Non-Qualified Stock Option (right to buy)   (4) $4.53   10/13/2017     D         200000      (8) 4/4/2023   Common Stock   200000   $6.65   (6) 0   D    
Non-Qualified Stock Option (right to buy)   (4) $4.52   10/13/2017     D         200000      (9) 3/14/2024   Common Stock   200000   $6.66   (6) 0   D    
Incentive Stock Option (right to buy)   (4) $8.83   10/13/2017     D         42725      (10) 3/16/2025   Common Stock   42725   $2.35   (6) 0   D    
Restricted Stock Unit   (4)   (1) 10/13/2017     M         10000      (11)   (11) Common Stock   10000     (1) 0   D    
Non-Qualified Stock Option (right to buy)   (4) $8.83   10/13/2017     D         97275      (10) 3/16/2025   Common Stock   97275   $2.35   (6) 0   D    
Restricted Stock Unit   (4)   (1) 10/13/2017     M         50000      (11)   (11) Common Stock   50000     (1) 0   D    
Incentive Stock Option (right to buy)   (12) $9.12   10/13/2017     D         11243      (13) 3/15/2026   Common Stock   11243   $2.06   (6) 0   D    
Non-Qualified Stock Option (right to buy)   (12) $9.12   10/13/2017     D         128757      (13) 3/15/2026   Common Stock   128757   $2.06   (6) 0   D    
Restricted Stock Unit   (12)   (1) 10/13/2017     M         15000      (11)   (11) Common Stock   15000     (1) 0   D    
Incentive Stock Option (right to buy)   (12) $9.65   10/13/2017     D         10843      (14) 3/8/2027   Common Stock   10843   $1.53   (6) 0   D    
Non-Qualified Stock Option (right to buy)   (12) $9.65   10/13/2017     D         129157      (14) 3/8/2027   Common Stock   129157   $1.53   (6) 0   D    
Restricted Stock Unit   (12)   (1) 10/13/2017     M         20000      (11)   (11) Common Stock   20000     (1) 0   D    

Explanation of Responses:
(1)  Each restricted stock unit represented a contingent right to receive one share of SCLN common stock upon settlement.
(2)  Includes 216 shares of SCLN common stock acquired under Issuer's 2016 Employee Stock Purchase Plan on October 6, 2017 and 746 shares of SCLN common stock acquired under Issuer's 2016 Employee Stock Purchase Plan on August 31, 2017.
(3)  Shares of SCLN common stock received in settlement of performance rights not constituting derivative securities.
(4)  Granted under Issuer's 2005 Equity Incentive Plan.
(5)  Under its terms the option became exercisable in installments with 25% vesting on April 5, 2012 and 2.0833% vesting each month thereafter until it became vested in full on April 5, 2015.
(6)  The option was canceled immediately prior to the merger of Issuer and Silver Delaware Investment Limited (the "Merger") in exchange for a cash payment per share from the Issuer in an amount equal to the excess of $11.18 per share over the exercise price.
(7)  Under its terms the option became exercisable in installments with 25% vesting on March 15, 2013 and 2.0833% vesting each month thereafter until it became vested in full on March 15, 2016.
(8)  Under its terms the option became exercisable in installments with 25% vesting on April 4, 2014 and 2.0833% vesting each month thereafter until it became vested in full on April 4, 2017.
(9)  Under its terms the option became exercisable in installments with 25% vesting on March 14, 2015 and 2.0833% vesting each month thereafter until it became vested in full immediately prior to the Merger.
(10)  Under its terms the option became exercisable in installments with 25% vesting on March 16, 2016 and 2.0833% vesting each month thereafter until it became vested in full immediately prior to the Merger.
(11)  Restricted stock units became fully vested and entitled to settlement immediately prior to the Merger and terminated upon settlement in shares of SCLN common stock.
(12)  Granted under Issuer's 2015 Equity Incentive Plan.
(13)  Under its terms the option became exercisable in installments with 25% vesting on March 15, 2017 and 2.0833% vesting each month thereafter until it became vested in full immediately prior to the Merger.
(14)  Under its terms the option became exercisable in installments with 25% to vest on March 8, 2018 and 2.0833% vesting each month thereafter until it became vested in full immediately prior to the Merger.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Blobel Friedhelm
950 TOWER LANE, SUITE 900
FOSTER CITY, CA 94404 		X
President, CEO, Director

Signatures
/s/ Friedhelm Blobel, Ph.D. 10/16/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Sciclone (NASDAQ:SCLN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Sciclone Charts.
Sciclone (NASDAQ:SCLN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Sciclone Charts.